Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mangoceuticals, Inc. ( (MGRX) ) has shared an announcement.
On August 26 and August 29, 2025, Mangoceuticals, Inc. entered into agreements with five accredited investors to sell 709,677 shares of restricted common stock at $1.55 per share, totaling $1,100,000. The shares were sold without public offering, underwriters, or agents, and include piggyback registration rights for one year. The securities are subject to transfer restrictions and were not registered under the Securities Act, relying on exemptions for accredited investors.
More about Mangoceuticals, Inc.
Average Trading Volume: 158,825
Technical Sentiment Signal: Hold
Current Market Cap: $24.86M
Learn more about MGRX stock on TipRanks’ Stock Analysis page.